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Research
Persistent organic pollutants (POPs) are a
family of lipophilic stable chemicals that bio-
accumulate in adipose tissue and create a last-
ing toxic body burden (Van den Berg et al.
2006). In addition to various known deleteri-
ous effects, POPs have recently been impli-
cated as a possible cause of cardiovascular
disease (CVD) (Mastin 2005). The associa-
tion between POPs and CVD is plausibly
causal through several biological mechanisms.
Exposure to polychlorinated biphenyls (PCBs)
or 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) is known to increase atherogenic
serum lipid levels in both animals and humans
(Bombick et al. 1984; Lovati et al. 1984; Swift
et al. 1981). In addition, these contaminants
cause direct damage to endothelial cells via
oxidative stress (Hennig et al. 2002; Stegeman
et al. 1995; Toborek et al. 1995). The combi-
nation of an elevation in serum lipids with
damage to endothelial cells would be expected
to increase the risk of CVD. There is also epi-
demiologic evidence for the association of
POPs with CVD, although it is not totally
consistent. Weakly or modestly elevated rate
ratios for mortality from ischemic heart disease
have been found in several cohorts, in which
there was occupational or accidental relatively
brief exposure to high doses of several POPs
(Bertazzi et al. 1998, 2001; Calvert et al. 1998;
Gustavsson and Hogstedt 1997; Hooiveld et al.
1998; Pesatori et al. 1998, 2003; Steenland
et al. 1999; Vena et al. 1998). One recent study
reported that residents living in ZIP code areas
contaminated with POPs had a statistically sig-
niﬁcant elevation in both coronary heart disease
(CHD) and acute myocardial infarction hospi-
tal discharge rates compared with clean ZIP
codes (Sergeev and Carpenter 2005).
There is ongoing controversy concerning
health effects of background, enduring envi-
ronmental exposure to endocrine disruptors
such as POPs (Kaiser 2000). There is a need
for epidemiologic study in the general popula-
tion because extrapolation from studies of high
exposure to selected POPs in occupational or
accidental settings may not be appropriate to
background exposure (Lee et al. 2006a). In
support of this assertion, we recently reported
a striking dose–response relation between
serum concentrations of POPs and diabetes in
the general population with background expo-
sure to POPs (Lee et al. 2006b). 
Serum concentrations of biologically
important POPs or their metabolites, including
dioxins and furans [polychlorinated dibenzo-p-
dioxins (PCDDs) and polychlorinated
dibenzofurans (PCDFs)], PCBs, hexachloro-
benzene (HCB), and several organochlorines
(OCs) used as pesticides, were measured in
subsamples of the National Health and
Nutrition Examination Survey (NHANES),
1999–2000 and 2001–2002 [National Center
for Health Statistics (NCHS) 2005]. The pre-
sent study was performed to investigate associ-
ations of prevalent self-reported CVD with the
serum concentrations of POPs; we restricted
the study to POPs that were widely prevalent
in order to ensure a valid CVD prevalence esti-
mate in the referent group with low exposure.
Methods
The 1999–2000 and 2001–2002 NHANES
conducted by the Centers for Disease Control
and Prevention (CDC) were designed to be
nationally representative of the noninstitu-
tionalized, U.S. civilian population on the basis
of a complex, multistage probability sample.
Approximately 9,965 persons, 2 months to
85 years of age, were studied in NHANES
1999–2000, and 11,039 persons were included
in NHANES 2001–2002. Details of the
NHANES protocol and all testing procedures
are available elsewhere (NCHS 2006a, 2006b).
The study protocol was reviewed and approved
by the CDC institutional review board; addi-
tionally, informed written consent was
obtained from all subjects before they took
part in the study.
PCDDs, PCDFs, PCBs, and OC pesti-
cides were measured in serum from a random
one-third subsample of people ≥ 12 years of
age in 1999 and 2000. In 2001 and 2002,
PCDDs, PCDFs, and coplanar PCBs were
measured in a random one-third subsample of
people ≥ 20 years of age, and OC pesticides
and other PCBs were measured in these peo-
ple and in a random one-third subsample of
people ≥ 12–19 years of age.
The NHANES data collection included a
standardized home interview followed by a
detailed physical examination in a mobile
evaluation clinic or the participant’s home.
Information on demographic characteristics,
ethnicity, and medical history of diabetes was
obtained in a household interview. Venous
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BACKGROUND: There is now increasing evidence that exposure to persistent organic pollutants
(POPs) can contribute to the development of inﬂammatory diseases such as atherosclerosis. 
OBJECTIVE: The objective of this study was to examine associations of serum concentrations of
POPs with self-reported history of cardiovascular disease (CVD).
DESIGN: Cross-sectional associations of serum POPs concentrations with the prevalence of self-
reported CVD were investigated in 889 adults ≥ 40 years of age in the National Health and
Nutrition Examination Survey, 1999–2002. We selected 21 POPs [3 polychlorinated dibenzo-p-
dioxins (PCDDs), 3 polychlorinated dibenzofurans (PCDFs), 5 dioxin-like polychlorinated
biphenyls (PCBs), 6 nondioxin-like PCBs, and 4 organochlorine (OC) pesticides] because they
were detectable in ≥ 60% of participants.
RESULTS: Dioxin-like PCBs, nondioxin-like PCBs, and OC pesticides were positively associated
with the prevalence of CVD only among females. Compared with those in the lowest quartile of
serum concentration, the odds ratios for CVD across increasing quartiles were 0.9, 2.0, and 5.0 for
dioxin-like PCBs (p for trend < 0.01), 1.2, 1.2, and 3.8 for nondioxin-like PCBs (p for trend
< 0.01), and 1.9, 1.7, and 4.0 for OC pesticides (p for trend = 0.03). PCDDs showed positive
trends with the prevalence of CVD in both males and females; adjusted odds ratios were 1.4, 1.7,
and 1.9 (p for trend = 0.07, males and females combined). 
CONCLUSIONS: Our ﬁndings need to be carefully interpreted because of the cross-sectional design
and use of self-reported CVD. Prospective studies are needed to clarify these associations. 
KEY WORDS: cardiovascular diseases, dioxin, persistent organic pollutants, pesticides, polychlori-
nated biphenyls. Environ Health Perspect 115:1204–1209 (2007). doi:10.1289/ehp.10184 avail-
able via http://dx.doi.org/ [Online 25 May 2007]blood and urine samples were collected and
shipped weekly at –20°C. PCDDs, PCDFs,
PCBs, and OC pesticides were all measured
as individual chemicals by high-resolution gas
chromatography/high-resolution mass spec-
trometry using isotope dilution for quantiﬁca-
tion. All of these analytes were measured in
approximately 5 mL serum using a modiﬁca-
tion of the method of Turner et al. (1997).
The POPs were reported on a lipid-adjusted
basis using concentrations of serum total cho-
lesterol and triglycerides.
Although 49 POPs were measured in both
NHANES 1999–2000 and 2001–2002, to
avoid bias in estimation among those below
the limit of detection (LOD), we selected the
21 POPs for which at least 60% of study sub-
jects had concentrations > LOD: 3 PCDDs,
3 PCDFs, 5 dioxin-like PCBs, 6 nondioxin-
like PCBs, and 4 OC pesticides. There were a
total of 1,054 study participants ≥ 40 years of
age with information on serum concentrations
of the 21 selected POPs. After excluding
165 diabetic participants, including newly
diagnosed cases, the ﬁnal sample size was 889.
We excluded those with diabetes from the pre-
sent study because simple adjustment for dia-
betic status may not be enough to exclude its
effect due to strong associations between serum
concentrations of POPs and diabetes (Lee et al.
2006b). However, inclusion of diabetic
patients did not materially change results.
For each POP, subjects with serum con-
centrations < LOD were regarded as the refer-
ence group, and subjects with detectable
values were categorized by cutoff points of
25th, 50th, and 75th percentile values. To
yield a cumulative measure of three PCDDs,
we summed the ranks according to magnitude
of detectable levels of the three POPs that
belong to the PCDDs, using the rank 0 for
any nondetectable value. The summary values
were categorized by cutoff points of 25th,
50th, and 75th percentile values. We assigned
and cumulated POP subclasses similarly for
the three PCDFs, the five dioxin-like PCBs,
the six nondioxin-like PCBs, and the four OC
pesticides. Thus, depending on the sum of
ranks of the several POPs belonging to the
speciﬁc POP subclass under consideration, the
subject could be in the lowest quartile or in a
higher quartile; however, if all POPs in the
subclass were nondetectable, the subject would
be placed in the lowest quartile. 
Participants were considered to have preva-
lent CVD if they answered “yes” to any of the
following questions: 
• “Has a doctor or other health professional
ever told you that you had CHD?” 
• “Has a doctor or other health professional ever
told you that you had angina/angina pectoris?” 
• “Has a doctor or other health professional ever
told you that you had heart attack/myocardial
infarction?” 
• “Has a doctor or other health professional
ever told you that you had a stroke?” 
We used logistic regression models to calcu-
late multivariate-adjusted odds ratios (ORs).
Adjusting CVD risk factors were age (years),
race/ethnicity, poverty income ratio (continu-
ous), body mass index (BMI; continuous),
cigarette smoking (never, former, or current),
cotinine levels (nanograms per milligram),
alcohol consumption (grams per day), leisure
time physical activity (vigorous, moderate, or
none), status of hypertension (yes/no), total
cholesterol (continuous), HDL (high-density
lipoprotein)-cholesterol (continuous), triglyc-
eride (continuous), and C-reactive protein
(continuous). We substituted median values
of noncases for missing BMI, poverty income
ratio, cotinine levels, or alcohol consumption
in 152 subjects. Exclusion of these individuals
did not change any conclusions, but it did
limit power in some analyses; therefore, they
were retained.
All statistical analyses were performed
using SAS 9.1 (SAS Institute Inc., Cary, NC,
USA) and SUDAAN 9.0 (Research Triangle
Institute, Research Triangle Park, NC, USA).
Estimates of main results were calculated
accounting for stratification and clustering
(Korn and Graubard 1991), and adjusting for
age, race, ethnicity, and poverty income ratio
instead of using sample weights; this adjust-
ment is regarded as a good compromise
between efficiency and bias (Graubard and
Korn 1999; Korn and Graubard 1991).
Because results were very similar with both
SAS 9.1 and SUDAAN 9.0, we present the
results based on SAS 9.1.
Results
The sample of 889 participants included 48%
males and 55% whites. Mean age ± SD was
60.4 ± 13.6 years (range, 40–85 years). In
Table 1, we present associations of known
CVD risk factors with five subclasses of
POPs, rather than the 21 specific POPs,
because our ﬁnal conclusion was made based
on the results of these ﬁve subclasses. Age was
the strongest and most important correlate of
serum concentrations of all ﬁve subclasses of
POPs in both sexes. However, associations of
other CVD risk factors with POPs appeared
to be substantially different depending on
speciﬁc classes of POPs. Subjects with white
race had lower concentrations of OC pesti-
cides in both sexes and of PCDDs in females,
but higher PCDFs or PCBs especially among
females. Those with greater income had
higher concentrations of PCBs but lower OC
pesticides. Obese people tended toward
higher concentrations of most POPs, except
nondioxin-like PCBs among females.
Smokers tended to have lower concentrations
of some POPs, whereas drinkers had higher
concentrations of PCBs. HDL cholesterol,
total cholesterol, and triglycerides were vari-
ously associated depending on subclasses of
POPs or sex. HDL cholesterol was positively
associated with PCBs in both sexes, but
POPs and cardiovascular diseases
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Table 1. Age-adjusted Spearman correlation coefﬁcientsa between ﬁve categories of lipid-adjusted POPs
with demographic or cardiovascular risk factors by sex.
Dioxin-like Nondioxin-like OC 
PCDDs PCDFs PCBs PCBs pesticides
Males 
Age 0.39** 0.23** 0.48** 0.44** 0.47**
Race NS NS NS NS –0.20**
Poverty income ratio  NS NS 0.14** NS NS
BMI 0.21** 0.10* 0.10*  NS 0.20**
Current smoker –0.16** NS –0.12*  NS NS
Exercise NS NS NS NS –0.11*
Alcohol consumption  NS NS 0.11*  0.10*  NS
HDL cholesterol NS NS NS 0.14** NS
Total cholesterol NS NS NS NS NS
Triglycerides NS NS NS NS 0.18**
C-reactive protein NS NS NS NS 0.11*
Females
Age 0.42** 0.36** 0.62** 0.51** 0.57**
Race NS 0.10* 0.10*  NS –0.30**
Poverty income ratio  NS NS 0.10*  0.10* –0.18**
BMI 0.10* NS NS –0.14** 0.19**
Current smoker –0.25** –0.10*  NS NS NS
Exercise NS NS NS NS NS
Alcohol consumption  NS NS NS NS NS
HDL cholesterol NS NS 0.10* 0.12** –0.17**
Total cholesterol NS –0.15** –0.09* NS NS
Triglycerides NS –0.10* NS –0.13** 0.16**
C-reactive protein NS NS NS –0.10* 0.15**
NS, not signiﬁcant. For race, white = 1 and others = 0. For current smoker, current = 1 and others = 0. For exercise, yes = 1
and no = 0.
aBefore calculating correlation coefﬁcients, detectable values of each POP were individually ranked, and the rank order
of the individual POPs in each subclass were summed to arrive at the subclass value; all nondetectable values were
ranked as 0. *p < 0.05. **p < 0.01.inversely associated with OC pesticides in
females. Because the serum concentrations of
POPs used in this study were already adjusted
for both total cholesterol and triglyceride,
most POPs were not associated or were even
inversely associated with total cholesterol or
triglycerides, except positive associations
between OC pesticides with triglycerides.
When lipid-unadjusted POPs levels were used,
all five subclasses of POPs were positively
associated with both total cholesterol and
triglycerides (data not shown). C-reactive pro-
tein was positively associated with OC pesti-
cides in both sexes, but was inversely
associated with nondioxin-like PCBs among
females. After adjusting for age, we found
positive pairwise correlations among serum
concentrations of the ﬁve subclasses of POPs
with correlation coefficients of 0.32–0.84 in
males and 0.28–0.86 in females. 
We found 108 prevalent self-reported
CVD cases (61 males and 47 females). They
consisted of 87 CHD cases (sum of CHD,
angina, and heart attack) and 40 stroke cases;
some persons reported more than one condi-
tion. Table 2 shows associations between the
ﬁve subclasses of POPs and the prevalence of
CVD by sex. PCDDs showed positive trends
with the prevalence of CVD in both males
and females, even though analyses stratiﬁed by
sex failed to reach statistical significance.
When both sexes were combined, the adjusted
ORs were 1.4, 1.7, and 1.9 (p for trend
= 0.07). PCDFs were unassociated with the
prevalence of CVD in either sex. Dioxin-like
PCBs, nondioxin-like PCBs, and OC pesti-
cides showed signiﬁcantly positive associations
with the prevalence of CVD only among
females. Adjusted ORs across quartiles of each
subclass were 0.9, 2.0, and 5.0 (p for trend
< 0.01); 1.2, 1.2, and 3.8 (p for trend < 0.01);
and 1.9, 1.7, and 4.0 (p for trend = 0.03) for
dioxin-like PCBs, nondioxin-like PCBs, and
OC pesticides, respectively. In the fully
adjusted models, serum levels of HDL choles-
terol, total cholesterol, and triglycerides were
included to eliminate residual confounding,
even though lipid adjusted POPs concentra-
tions were used. However, dropping individ-
ual lipids from the list of covariates did not
change results. 
In Tables 3 and 4, we further examined
associations of prevalence of CVD with spe-
cific POPs belonging to subclasses that
showed positive associations in Table 2. In the
case of PCDDs, we presented the results in
both males and females (Table 3). Among the
three PCDDs, only 1,2,3,6,7,8-hexa-
chlorodibenzo-p-dioxin showed significant
Ha et al.
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Table 2. Number of cases/total number and adjusted OR (95% CI) for prevalence of cardiovascular diseases
by quartiles of PCDDs, PCDFs, dioxin-like PCBs, nondioxin-like PCBs, and OC pesticides in males and
females. 
Analyte < 25th 25th to < 50th 50th to < 75th ≥ 75th ptrend
Males
PCDDs 7/106 12/107 19/107 23/107
Referent 1.7 (0.6–4.7) 2.1 (0.8–5.9) 2.2 (0.8–6.1) 0.14
PCDFs 13/106 12/107 17/107 19/107
Referent  0.7 (0.3–1.8) 0.9 (0.4–2.2) 0.7 (0.3–1.7) 0.60 
Dioxin-like PCBs 6/106 16/107 17/107 22/107
Referent 2.2 (0.8–6.5) 1.8 (0.6–5.3) 1.7 (0.6–5.5) 0.64 
Nondioxin-like PCBs 7/106 17/107 14/107 23/107
Referent 2.3 (0.8–6.4) 1.3 (0.5–3.9) 1.8 (0.6–5.0) 0.61
OC pesticides 10/106 12/107 18/108 21/106
Referent 0.7 (0.2–1.9) 0.9 (0.3–2.4) 0.9 (0.3–2.3) 0.96
Females
PCDDs 8/115 9/116 11/116 19/115
Referent 1.1 (0.3–3.3) 1.5 (0.5–4.3) 2.0 (0.7–6.4) 0.16
PCDFs 9/115 10/116 13/116 15/115
Referent  0.9 (0.3–2.5) 1.1 (0.4–3.0) 1.0 (0.3–2.8) 0.92
Dioxin-like PCBs 4/115 8/116 12/116 23/115
Referent 0.9 (0.2–3.5) 2.0 (0.5–7.6) 5.0 (1.2–20.4) < 0.01
Nondioxin-like PCBs 5/115 9/115 9/117 24/115
Referent 1.2 (0.4–4.0) 1.2 (0.4–4.2) 3.8 (1.1–12.8) 0.02
OC pesticides 3/115 9/116 10/116 25/115
Referent 1.9 (0.5–7.7) 1.7 (0.4–7.1) 4.0 (1.0–17.1) 0.03
ORs were adjusted for age, race, poverty income ratio, BMI, cigarette smoking, serum cotinine, alcohol consumption,
exercise, HDL cholesterol, total cholesterol, triglycerides, hypertension, and C-reactive protein. Detectable values of
each POP were individually ranked, and the rank orders of the individual POPs in each subclass were summed to arrive at
the subclass value. All not detectable values were ranked as 0. The summary values were categorized by cutoff points of
25th, 50th, and 75th values of the sum of ranks.
Table 3. Concentration (pg/g of lipid), number of cases/total number, and adjusted OR (95% CI) for prevalence of self-reported cardiovascular diseases by category
of PCDDs in males and females. 
Detection Not  Detectable
Analyte rate (%) detectable < 25th 25th to < 50th 50th to < 75th ≥ 75th ptrend
Males
1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin 82.2 — 26.6a 42.1 61.3 111
5/76 3/86 14/89 21/89 18/87
Referent 0.9 (0.2–4.0) 4.3 (1.3–14.2) 4.1 (1.3–12.6) 2.5 (0.8–7.7) 0.04
1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin 89.5 — 20.7 40.0 61.7 111
3/45 12/95 17/96 11/96 18/95
Referent 3.2 (0.8–13.3) 3.7 (0.9–15.4) 1.7 (0.4–7.6) 2.4 (0.5–10.3) 0.94
1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin 82.0 — 192 310 469 899
4/77 7/87 18/88 16/88 16/87
Referent 1.5 (0.4–6.0) 3.7 (1.1–12.6) 2.7 (0.8–9.6) 2.1 (0.6–7.7) 0.28
Females
1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin 83.8 — 27.6 45.9 66.1 111
6/75 5/96 3/97 12/97 21/97
Referent 1.0 (0.3–3.7) 0.4 (0.1–1.9) 1.7 (0.5–5.2) 2.8 (0.9–8.6) 0.04
1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin 93.1 — 25.5 50.2 76.6 135
3/32 12/107 7/108 11/108 14/107
Referent  1.6 (0.3–7.9) 1.3 (0.2–7.7) 2.2 (0.4–12.0) 1.9 (0.3–10.8) 0.45
1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin 92.9 — 278 445 660 1,170
4/33 10/107 4/107 12/108 17/107
Referent 0.6 (0.1–2.4) 0.2 (0.1–1.1) 0.7 (0.2–2.7) 0.7 (0.2–2.8) 0.74
ORs were adjusted for age, race, poverty income ratio, BMI, cigarette smoking, serum cotinine, alcohol consumption, exercise, HDL cholesterol, total cholesterol, triglycerides, hyper-
tension, and C-reactive protein. 
aMedian concentrations are displayed in each category.trends in both males and females. Even
though 1,2,3,4,6,7,8-heptachlorodibenzo-p-
dioxin and 1,2,3,4,6,7,8,9-octachlorodibenzo-
p-dioxin did not show linear trends, the risk
appeared to substantially increase from the
first or second category of detectable range
compared with nondetectable value, especially
in males. On the other hand, most dioxin-like
PCBs, nondioxin-like PCBs, and OC pesti-
cides showed dose–response relations with
CVD in females (Table 4).
In all analyses, we further considered self-
reported weight loss in the past 1 or 10 years
as possible confounders because weight loss
increases serum concentrations of POPs and
because patients with a history of CVD may
intentionally decrease their body weight after
diagnosis. However, the adjustment for weight
loss did not change the results (data not
shown). When the dataset was reanalyzed
using the 87 CHD cases as the outcome vari-
able, the trends were very similar with those of
CVD cases (data not shown). 
Discussion
This cross-sectional study demonstrated that
the background exposure to POPs was posi-
tively associated with the prevalence of CVD
in the U.S. general population. Details of asso-
ciations were substantially different depending
on speciﬁc subclasses of POPs or sex, but the
associations with CVD suggested by the data
are as strong as those of traditional CVD risk
factors. 
Our findings are in general agreement
with, but stronger than, those of previous
prospective cohort studies among subjects
exposed to high concentrations of selected
POPs in occupational or accidental settings
(Bertazzi et al. 1998, 2001; Calvert et al. 1998;
Gustavsson and Hogstedt 1997; Hooiveld
et al. 1998; Pesatori et al. 1998, 2003;
Steenland et al, 1999; Vena et al. 1998).
Considering that exposure levels in the present
study were much lower than those in previous
POPs and cardiovascular diseases
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Table 4. Concentration (ng/g of lipid), number of cases/total number, and adjusted OR (95% CI) for prevalence of cardiovascular diseases by categories of speciﬁc
POPs belonging to dioxin-like PCBs, nondioxin-like PCBs, and OC pesticides in females.
Detection Not  Detectable
Analyte rate (%) detectable < 25th 25th to < 50th 50th to < 75th ≥ 75th ptrend
Dioxin-like PCBs
2,4,4´,5-Tetrachlorobiphenyl (PCB-74) 87.2 — 8.2a 13.9 20.5 36.1
2/59 6/100 8/101 8/101 23/101
Referent 1.1 (0.2–6.1) 1.2 (0.2–6.4) 1.3 (0.2–7.3) 4.5 (0.8–24.8) 0.01
2,3´,4,4´,5-Pentachlorobiphenyl (PCB-118) 87.7 — 8.6 15.2 26.4 49.3
2/57 9/98 5/105 8/101 23/101
Referent  1.8 (0.3–9.4) 0.6 (0.1–4.1) 1.3 (0.2–7.8) 4.5 (0.8–25.5) 0.02
3,3´,4,4´,5-Pentachlorobiphenyl (PCB-126) 88.1 — 18.3 31.6 51.0 95.4
3/55 9/101 7/102 11/102 17/102
Referent 1.3 (0.3–5.8) 1.4 (0.3–6.6) 1.6 (0.4–7.4) 2.6 (0.6–12.2) 0.17
2,3,3´,4,4´,5-Hexachlorobiphenyl (PCB-156) 71.4 — 5.9 9.0 12.1 20.9
3/132 5/83 7/83 15/81 17/83
Referent 2.0 (0.4–9.5) 2.6 (0.6–12.0) 9.2 (2.1–39.4) 10.4 (2.3–46.7) < 0.01
3,3´,4,4´,5,5´-Hexachlorobiphenyl (PCB-169) 89.6 — 13.3 21.7 32.4 51.0
3/48 5/103 8/104 16/103 15/104
Referent 0.6 (0.1–2.7) 0.9 (0.2–3.9) 1.2 (0.3–5.3) 1.2 (0.3–5.1) 0.38
Nondioxin-like PCBs
2,2´,4,4´5-Pentachlorobiphenyl (PCB-99) 74.2 — 6.0 9.7 14.5 26.9
10/119 4/84 3/87 12/86 18/86
Referent 0.3 (0.1–1.1) 0.2 (0.1–1.0) 1.1 (0.4–3.0) 1.5 (0.5–3.9) 0.08
2,2´,3,4,4´,5-Hexachlorobiphenyl (PCB-138) 87.7 — 18.3 32.1 51.3 91.0
1/57 10/100 4/102 7/102 25/101
Referent 6.8 (0.8–58.9) 1.6 (0.2–15.9) 3.6 (0.4–32.8) 13.4 (1.6–115.0) < 0.01
2,2´,4,4´,5,5´-Hexachlorobiphenyl (PCB-153) 90.3 — 27.3 48.5 71.8 127.0
1/45 7/104 8/105 9/103 22/105
Referent 3.7 (0.4–34.8) 3.0 (0.3–27.1) 3.6 (0.4–33.5) 10.4 (1.1–94.1) < 0.01
2,2´,3,3´,4,4´,5-Heptachlorobiphenyl (PCB-170) 88.3 — 9.2 15.2 21.9 36.4
1/54 5/102 11/101 10/103 20/102
Referent 2.5 (0.3–23.3) 3.8 (0.4–33.3) 3.5 (0.4–32.1) 9.2 (1.0–84.5) 0.01
2,2´,3,4,4´,5,5´-Heptachlorobiphenyl (PCB-180) 92.2 — 18.9 34.6 51.3 86.4
1/36 6/107 10/106 10/107 20/106
Referent 1.8 (0.2–16.5) 2.0 (0.2–17.9) 2.0 (0.2–18.7) 4.5 (0.5–40.9) 0.07
2,2´,3,4´,5,5´,6-Heptachlorobiphenyl (PCB-187) 82.5 — 7.4 11.2 16.8 30.4
1/86 8/93 9/98 12/95 17/95
Referent 5.0 (0.6–43.5) 3.5 (0.4–30.2) 5.8 (0.7–50.1) 7.4 (0.9–63.6) 0.07
OC pesticides
p,p´-Dichlorodiphenyltrichloroethane 100 — 189 556 1,145 2,440
— 8/115 9/116 10/116 20/115
Referent 0.8 (0.3–2.9) 0.7 (0.2–2.1) 1.7 (0.6–4.9) 0.22 
Oxychlordane 93.7 — 12.1 20.2 31.4 50.5
0/29 3/108 9/108 9/110 26/107
Referent 1.9 (0.4–7.7) 1.7 (0.4–7.6) 6.8 (1.6–29.3) < 0.01
trans-Nonachlor 98.3 — 15.4 27.2 42.4 80.8
0/8 2/113 10/114 12/114 23/113
Referent 3.7 (0.7–18.6) 3.4 (0.7–17.1) 6.5 (1.3–33.6) 0.03
Heptachlor epoxide 68.2 — 5.9 9.2 13.1 23.9
9/147 1/78 8/80 13/79 16/78
Referent 0.1 (0.1–1.3) 1.1 (0.3–3.2) 2.0 (0.7–5.8) 1.9 (0.6–5.7) 0.05
ORs were adjusted for age, race, poverty income ratio, BMI, cigarette smoking, serum cotinine, alcohol consumption, exercise, HDL cholesterol, total cholesterol, triglycerides, hypertension,
and C-reactive protein. 
aMedian concentrations are displayed in each category.studies, this may be a puzzling finding.
Interestingly, we also reported striking dose–
response relations between serum concentra-
tions of POPs and prevalent diabetes in the
same NHANES dataset (Lee et al. 2006b). In a
recent editorial (Lee et al. 2006a), we discussed
that epidemiologic studies in general popula-
tions who are neither occupationally nor acci-
dentally exposed may be critical to investigate
possible health effects of POPs in humans.
Specifically, previous studies often failed to
select a true reference group with very low
exposure levels to POPs, for example, by exam-
ining people with very low serum concentra-
tions of POPs, despite persistence of the POPs
in adipose tissue and consistent background
environmental exposure to them. They gener-
ally did not examine the possibility that a mix-
ture of POPs could have an additive or
synergistic effect on health, as we have done by
employing a summary measure that considered
joint health effects of POPs with possibly dif-
ferent toxicologic properties. These studies did
not consider the possibility of nonlinear associ-
ations (Lee et al. 2006a). All of these points
can lead to substantial underestimation of risk
or masking of true risk. 
On the other hand, the fact that CVD was
associated with various POPs with different
toxicologic proﬁles may also be consistent with
the possibility that the observed relations are
not causal. It is entirely possible that the POPs
investigated in the present study are not them-
selves causally related to CVD. Rather, they
could be surrogates of exposure to a mixture of
POPs in the general population because there
are high correlations among serum concentra-
tions of various POPs in the human body.
Furthermore, we can not completely exclude
the possibility of reverse causality; CVDs may
alter metabolism so as to increase serum con-
centrations of POPs. However, if reverse
causality were occurring, it would be sensible
to expect that all POPs in both sexes would be
associated with CVD, rather than selected
POPs as we observed. 
The NHANES data provided a unique
chance to investigate the possible associations
between serum concentrations of various
POPs and CVD in a random sample of the
general population, despite the recognition
that self-reported CVD as the dependent vari-
able is less accurate than physician-diagnosed
CVD. Previous epidemiologic studies have
focused on selected populations, often occupa-
tionally or accidentally exposed to high levels
of selected POPs. 
In the present study, the speciﬁc subclasses
of POPs related to CVD appeared to differ by
sex. Serum concentrations of PCDDs were
positively associated with prevalence of CVD
among males, but females showed strong posi-
tive associations with dioxin-like or non-
dioxin-like PCBs or OC pesticides. It is
well-known that males and females differ in
many aspects of vulnerability to environmen-
tal xenobiotics and other stressors (Gochfeld
2006). Differences between the sexes in the
response of nonreproductive cells, in addition
to reproductive cells, to TCDD or PCBs have
been observed in several animal studies (Enan
et al. 1996; Vega-Lopez et al. 2007; Wyde
et al. 2001). Because most occupational epi-
demiologic studies on POPs have been per-
formed among men, it is largely unknown
whether various health effects of POPs
between men and women are similar or not. In
our previous study of diabetes (Lee et al.
2006b), the associations of POPs did not differ
between sexes. 
There is increasing experimental evidence
that exposure to POPs such as TCDD or
PCBs can lead to cardiovascular toxicity and
atherosclerosis. A number of biochemical
changes induced by POPs observed in in vitro
or in vivo experimental studies are viewed as
atherogenic. PCBs or TCDD can compromise
the normal function of vascular endothelial
cells by activating oxidative stress–sensitive sig-
naling pathways and subsequent proinﬂamma-
tory events critical in the pathology of
atherosclerosis and CVD (Hennig et al. 2002;
Stegeman et al. 1995; Toborek et al. 1995). In
addition, exposure to TCDD increased serum
cholesterol, triglyceride, and phospholipids
and suppressed low-density lipoprotein recep-
tors in the liver (Bombick et al. 1984; Lovati
et al. 1984; Swift et al. 1981). Moreover,
TCDD promoted the differentiation of
macrophages to atherogenic foam cells or
deregulated several genes in cell proliferation
and apoptosis in smooth muscle cell (Dalton
et al. 2001; Vogel et al. 2004). 
Unlike evidence from experimental studies
in which the affinity to aryl hydrocarbon
receptor (AhR) was important to induce
atherosclerosis (Hennig et al. 2002; Stegeman
et al. 1995; Toborek et al. 1995), the strengths
of association of each POP belonging to the
category of PCDDs or PCDFs did not appear
to be correlated with the toxic equivalent fac-
tors (TEFs) of each POP. The concept of
TEFs, a measure of the ability to bind to the
AhR, was developed to facilitate risk assess-
ment and regulatory control of exposure to
complex PCDD, PCDF, and PCB mixtures
(Van den Berg et al. 2006). Also, in the present
study, nondioxin-like PCBs appeared to show
more consistent and stronger associations than
dioxin-like PCBs. Even among the dioxin-like
PCBs, PCBs with low TEFs tended to show
stronger associations than those with high
TEFs. Our previous study of the associations
between POPs and diabetes similarly reported
no relation between strength of association and
TEF of each POP (Lee et al. 2006b). These
ﬁndings suggest that the afﬁnity to AhR may
not be a critical pathway of toxicity of POPs in
humans for some outcomes, unlike findings
from cells or animal models. Alternatively, the
associations of some POPs with CVD observed
in the present study may not be direct as we
discussed above. 
The present study has several limitations,
primarily because of its cross-sectional design,
but also because diagnosis of CVD was self-
reported and fatal events were not even con-
sidered. The expense and blood volume
needed to measure POPs in a population sam-
ple are such that such data are rare; therefore,
the NHANES data may offer important
insights, despite these limitations. In the case
of misdiagnosis, we expect that the misclassiﬁ-
cation would be nondifferential, leading to the
underestimation of ORs. Misclassiﬁcation bias
is also possible because some subjects with a
higher POP value but a lower sample volume
could be classiﬁed in the reference group, or
vice versa. Such misclassiﬁcation is also likely
to be nondifferential because sample volume is
probably unrelated to prevalence of CVD. 
In summary, we found positive associa-
tions between serum concentrations of some
POPs and the prevalence of CVD in this sam-
ple of the U.S. population. Thus, prospective
study of the relation between background
dioxin exposure and validated CVD should
be a priority in further study of these associa-
tions. Both the exposure and the disease have
substantial prevalence, and the public health
signiﬁcance of a causal relation of POPs with
CVD should be noted.
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